The S&P 500 tops a record high that 'clears the charts' of resistance
Technical analysts take the milestone as a bullish development for equities even amid lingering concerns of slowing economic growth.
Stay updated with breaking news from Johnson Amp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Technical analysts take the milestone as a bullish development for equities even amid lingering concerns of slowing economic growth.
/PRNewswire/ -- Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for...
2024 kicked off with a surprise move higher in yields, unnerving investors.
The targets are shares of companies with mix of growth, reliable profits and strong balance sheets
The JPMorgan Healthcare Conference was likely just the beginning of another year of heightened interest and investments in ADC cancer drugs.